The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: A controlled clinical trial using computerised assessments

L. G. Walker*, K. P. Wesnes, S. D. Heys, M. B. Walker, J. Lolley, O. Eremin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: A controlled clinical trial using computerised assessments'. Together they form a unique fingerprint.

Medicine & Life Sciences